Among the nine genes in the prognostic model that we constructed, GABARAPL1 knockdown has been shown to inhibit the growth of prostate cancer cells in vitro or in vivo (Keulers et al., 2015). This evidence concerns the gene GABARAPL1 and prostate cancer.